Articles related to ATRIAL FIBRILLATION (AFIB)

The Heart Failure Society of America released a scientific statement establishing diagnostic criteria and a treatment framework for heart failure with mildly reduced ejection fraction, a phenotypically heterogeneous group historically underrepresented in dedicated interventional trials.

First-line pulsed field catheter ablation outperformed antiarrhythmic drug therapy for rhythm control at one year in patients with persistent atrial fibrillation, with similar serious adverse event rates.

ACC, AHA, and HRS jointly updated the 2015 advanced training statement for clinical cardiac electrophysiology, adding new required competencies and revised procedural benchmarks for fellowship training.

A year‑in‑review article highlights major cardiovascular themes from 2025, including evolving approaches to hypertension, myocardial infarction management, and atrial fibrillation care.

There needs to be increased awareness among primary care doctors and general cardiologists that patients with persistent symptomatic AF are sometimes better served by promptly scheduling a cardioversion while waiting for an appointment with an electrophysiologist.

The primary study outcome was a composite of serious bleeding events leading to hospitalization. Secondary study outcomes included composites of stroke or systemic embolism.